ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
VERAXA and Quadira Enter ADC Development Partnership contractpharma
June 16, 2021?VERAXA Biotech GmbH (former Velabs Therapeutics GmbH), an ADC engineering and functional antibody screening company, has entered into a partnership with Quadira Biosciences AG of Zug, Switzerland, to develop a suite of novel ADCs for the treatment of ... -
VERAXA Biotech and Quadira Biosciences Enter Partnership on ADC Development b3cnewswire
June 15, 2021VERAXA Biotech GmbH (former Velabs Therapeutics GmbH), announced today that it has entered into a partnership agreement with Quadira Biosciences AG, Zug, Switzerland， to jointly develop a suite of novel ADCs for the treatment of oncological conditions.
Pharma Sources Insight January 2025
